<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1539">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05141123</url>
  </required_header>
  <id_info>
    <org_study_id>Preloaded REGISTRY</org_study_id>
    <nct_id>NCT05141123</nct_id>
  </id_info>
  <brief_title>Registry of Patients Treated by Preloaded Fenestrated Stent-graft Designs for Complex Endovascular Aortic Procedures (PLD.REG.)</brief_title>
  <official_title>A Physician-initiated, International, Multi-center, Ambispective, Observational Registry of Patients Treated by Preloaded Fenestrated Stent-graft Designs for Complex Endovascular Aortic Procedures</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>IRCCS San Raffaele</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>IRCCS San Raffaele</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to evaluate the outcomes of the preloaded stent-graft design (PLD) in&#xD;
      the routine treatment of para-renal and thoraco-abdominal aneurysms. Results and&#xD;
      postoperative events are reported in accordance with the current reporting standards for&#xD;
      endovascular aortic repair prepared and revised by the Ad Hoc Committee for Standardized&#xD;
      Reporting Practices in Vascular Surgery of The Society for Vascular Surgery/American&#xD;
      Association for Vascular Surgery.&#xD;
&#xD;
      The Registry will include approximately 300 patients treated from January 2015 to May 2021&#xD;
      (retrospective arm) and June 2021 to June 2023 (perspective arm) for the routine treatment of&#xD;
      para-renal and thoraco-abdominal aneurysms. To reach 300 patients, the enrollments can be&#xD;
      extended until June 2026.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 20, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical success</measure>
    <time_frame>30 days</time_frame>
    <description>absence of death, type I/III endoleak, graft infection/thrombosis, aneurysm expansion and/or rupture, conversion to open repair, or new treatment-related thoraco-abdominal pathologies</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Renal Aneurysm</condition>
  <condition>Aneurysm Thoracic</condition>
  <condition>Aneurysm Abdominal</condition>
  <arm_group>
    <arm_group_label>Preloaded Fenestrated Stent-graft Designs for Endovascular Aortic Procedures</arm_group_label>
    <description>Patients presenting with an acute (up to two weeks from the onset) and subacute (between 3 and 12 weeks from the onset) type B dissection with a proximal suitable non-dissected landing zone in the aortic arch or descending thoracic aorta (supra-aortic trunks debranching may be employed to obtain an adequate proximal landing zone)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Complex Endovascular Aortic Procedures trated by Preloaded Fenestrated Stent-graft Designs for</intervention_name>
    <description>Evaluate the outcomes of the preloaded stent-graft design (PLD) in the routine treatment of para-renal and thoraco-abdominal aneurysms</description>
    <arm_group_label>Preloaded Fenestrated Stent-graft Designs for Endovascular Aortic Procedures</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The study will include approximately 300 patients treated from January 2015 to May 2021&#xD;
        (retrospective arm) and June 2021 to June 2023 (perspective arm) for the routine treatment&#xD;
        of para-renal and thoraco-abdominal aneurysms. To reach 300 patients, the enrollments can&#xD;
        be extended until June 2026.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        -Patients presenting with an acute (up to two weeks from the onset) and subacute (between 3&#xD;
        and 12 weeks from the onset) type B dissection with a proximal suitable non-dissected&#xD;
        landing zone in the aortic arch or descending thoracic aorta (supra-aortic trunks&#xD;
        debranching may be employed to obtain an adequate proximal landing zone&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Anatomy requiring sealing in the distal descending thoracic aorta may not be&#xD;
             appropriate for a 50 cm sheath due to the risk of it being too short and the graft not&#xD;
             reaching the intended landing zone;&#xD;
&#xD;
          -  Celiac trunk or superior mesenteric branch design that makes the graft excessively&#xD;
             long;&#xD;
&#xD;
          -  Inability or refusal to give informed consent;&#xD;
&#xD;
          -  Simultaneously participating in another investigative device or drug study;&#xD;
&#xD;
          -  Frank rupture;&#xD;
&#xD;
          -  Systemic infection (eg, sepsis);&#xD;
&#xD;
          -  Allergy to stainless steel, polyester, solder (tin, silver), polypropylene, nitinol,&#xD;
             or gold;&#xD;
&#xD;
          -  Untreatable reaction to contrast, which, in the opinion of the investigator, cannot be&#xD;
             adequately premedicated.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Luca Bertoglio, Prof</last_name>
    <phone>+390226437381</phone>
    <email>bertoglio.luca@hsr.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>McGovern Medical School</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Gustavo Oderich, Prof</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Aortic Centre Marie Lannelongue, Groupe Hospitalier Paris Saint Joseph, Université Paris Saclay</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Stephan Haulon, Prof.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Policlinico S. Orsola Malpighi</name>
      <address>
        <city>Bologna</city>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Mauro Gargiulo, Prof.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Vascular Center Malmö, Skåne University Hospital</name>
      <address>
        <city>Malmö</city>
        <country>Sweden</country>
      </address>
    </facility>
    <contact>
      <last_name>Nuno Dias, Prof</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospitals Birmingham NHS Foundation Trust</name>
      <address>
        <city>Birmingham</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <contact>
      <last_name>Donald Adam, Prof</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Royal Free Hospital</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <contact>
      <last_name>Tara Mastracci, Prof</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
    <country>Italy</country>
    <country>Sweden</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Greenberg RK, West K, Pfaff K, Foster J, Skender D, Haulon S, Sereika J, Geiger L, Lyden SP, Clair D, Svensson L, Lytle B. Beyond the aortic bifurcation: branched endovascular grafts for thoracoabdominal and aortoiliac aneurysms. J Vasc Surg. 2006 May;43(5):879-86; discussion 886-7.</citation>
    <PMID>16678676</PMID>
  </reference>
  <reference>
    <citation>Mohabbat W, Greenberg RK, Mastracci TM, Cury M, Morales JP, Hernandez AV. Revised duplex criteria and outcomes for renal stents and stent grafts following endovascular repair of juxtarenal and thoracoabdominal aneurysms. J Vasc Surg. 2009 Apr;49(4):827-37; discussion 837. doi: 10.1016/j.jvs.2008.11.024. Epub 2009 Feb 23.</citation>
    <PMID>19233600</PMID>
  </reference>
  <reference>
    <citation>Manning BJ, Harris PL, Hartley DE, Ivancev K. Preloaded fenestrated stent-grafts for the treatment of juxtarenal aortic aneurysms. J Endovasc Ther. 2010 Aug;17(4):449-55. doi: 10.1583/10-3024.1.</citation>
    <PMID>20681756</PMID>
  </reference>
  <reference>
    <citation>Kitagawa A, Greenberg RK, Eagleton MJ, Mastracci TM. Zenith p-branch standard fenestrated endovascular graft for juxtarenal abdominal aortic aneurysms. J Vasc Surg. 2013 Aug;58(2):291-300. doi: 10.1016/j.jvs.2012.12.087. Epub 2013 Apr 20.</citation>
    <PMID>23611709</PMID>
  </reference>
  <reference>
    <citation>Bisdas T, Donas KP, Torsello G, Austermann M. Technical assessment of the preloaded fenestrated stent-graft in the management of pararenal aortic aneurysms. J Endovasc Ther. 2013 Aug;20(4):461-8. doi: 10.1583/13-4310.1.</citation>
    <PMID>23914852</PMID>
  </reference>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 19, 2021</study_first_submitted>
  <study_first_submitted_qc>November 19, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 2, 2021</study_first_posted>
  <last_update_submitted>November 19, 2021</last_update_submitted>
  <last_update_submitted_qc>November 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>IRCCS San Raffaele</investigator_affiliation>
    <investigator_full_name>Bertoglio Luca</investigator_full_name>
    <investigator_title>Prof</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm, Abdominal</mesh_term>
    <mesh_term>Aortic Aneurysm, Thoracic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

